Abstract:Background:Tumor cell inhibition is a pivotal focus in anti-cancer research, and extensive investigations have been conducted regarding the role of p53. Numerous studies have highlighted its close association with reactive oxygen species (ROS). However, the precise impact of the antioxidant glutathione (GSH) in this context remains inadequately elucidated. Here, we will elucidate the anti-cancer mechanisms mediated by p53 following treatment with GSH. Methods:In this study, we employed a p53 gene knockout approach in SW480 colorectal cells and conducted comprehensive analyses of 20 amino acids and proteomics using liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS). Results:These analyses unveiled profound alterations in amino acids and proteins triggered by GSH treatment, shedding light on novel phenomena and delineating the intricate interplay between GSH and cellular proteins. The deletion of the p53 gene exerts a profound influence on tumor cell proliferation. Moreover, tumor cell proliferation is significantly affected by elevated GSH levels. Importantly, in the absence of the p53 gene, cells exhibit heightened sensitivity to GSH, leading to inhibited cell growth. The combined therapeutic approach involving GSH and p53 gene deletion expedites the demise of tumor cells. It is noteworthy that this treatment leads to a marked decline in amino acid metabolism, particularly affecting the down-regulation of methionine (Met) and phenylalanine (Phe) amino acids. Among the 41 proteins displaying significant changes, 8 exhibit consistent alterations, with 5 experiencing decreased levels and 3 demonstrating increased quantities. These proteins primarily participate in crucial cellular metabolic processes and immune functions. Conclusions:In conclusion, the concurrent administration of GSH treatment and p53 gene deletion triggers substantial modifications in the amino acid and protein metabolism of tumor cells, primarily characterized by down-regulation. This, in turn, compromises cell metabolic activity and immune function, ultimately culminating in the demise of tumor cells. These newfound insights hold promising implications and could pave the way for the development of straightforward and efficacious anti-cancer treatments.

The Fundamental Role of the P53 Pathway in Tumor Metabolism and Its Implication in Tumor Therapy

The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy.

Emerging Roles of the Tumor Suppressor p53 in Metabolism

P53 and Regulation of Tumor Metabolism

Tumor Suppressor P53 and Its Mutants in Cancer Metabolism.

P53 and Cancer Metabolism

p53 regulates lipid metabolism in cancer

p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment.

The p53 Pathway and Metabolism: The Tree That Hides the Forest

p53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect

Tumor suppressor p53 and metabolism.

p53-Mediated Indirect Regulation on Cellular Metabolism: From the Mechanism of Pathogenesis to the Development of Cancer Therapeutics

Roles of P53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer

Research Progress on p53-involved Metabolic Regulation

Regulation of Metabolic Activity by p53

Progress and Prospects: Roles of P53 in Tumor Development

Targeting p53 pathways: mechanisms, structures, and advances in therapy

Unveiling the Impact of Glutathione (GSH) and P53 Gene Deletion on Tumor Cell Metabolism by Amino Acid and Proteomics Analysis

Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer.